Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2023

Month: June

Request Number: A-2022-001256

Request Summary: Adverse Drug Reaction (ADR) for AGALSIDASE ALFA. Report number: E2B_05845814. ADRs for MEZAVANT. Report numbers: E2B_05870258, E2B_05864070. ADRs for LANSOPRAZOLE. Report numbers: E2B_05853179, E2B_05844531, E2B_05840815, 001021389, E2B_05875371, E2B_05874054.

Disposition: Disclosed in part

Number of pages: 333

Date modified: